Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to …
![RYBREVANT FDA Submission](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/12/pexels-gustavo-fring-3985163.jpg?resize=760%2C427&ssl=1)
![RYBREVANT FDA Submission](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/12/pexels-gustavo-fring-3985163.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to …